Trial Profile
Anti-Factor Xa Activity Values is correlated with prothrombin time-international normalized ratio (PT-INR) and activated partial thromboplastin time (APTT) at peak and trough times in Patients on Edoxaban Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2018
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 16 Dec 2018 New trial record
- 14 Nov 2018 Results presented at the 91st Annual Scientific Sessions of the American Heart Association